ProductsBack/ELISA Kit for Nitric Oxide Synthase 2, Inducible (NOS2)

ELISA Kit for Nitric Oxide Synthase 2, Inducible (NOS2)

Name: ELISA Kit for Nitric Oxide Synthase 2, Inducible (NOS2)
SKU: SEA837HU_U80
Availability: BackOrder

SEA837HU

Product group Assays

Overview

Supplier
Cloud-Clone Corp.
Product Name
ELISA Kit for Nitric Oxide Synthase 2, Inducible (NOS2)
Delivery Days Customer
12
Assay Detection Range
0.156-10ng/mL
Assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Nitric Oxide Synthase 2, Inducible (NOS2) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with ...
Assay Sensitivity
The minimum detectable dose of this kit is typically less than 0.055ng/mL
Assay Specificity
This assay has high sensitivity and excellent specificity for detection of Nitric Oxide Synthase 2, Inducible (NOS2). No significant cross-reactivity or interference between Nitric Oxide Synthase 2, Inducible (NOS2) and analogues was observed.
Assay Test Principle
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Nitric Oxide Synthase 2, Inducible (NOS2). Standards or samples are then added to the ...
Assay Time
3h
Certification
Research Use Only
UNSPSC
41116158

The Effects of Intermittent Hypoxic-Hyperoxic Exposures on Lipid Profile and Inflammation in Patients With Metabolic Syndrome. Afina AB et al., 2021, Front Cardiovasc Med
Read more
Whole-Body Cryotherapy Increases the Activity of Nitric Oxide Synthase in Older Men. Wiecek M et al., 2021 Jul 16, Biomolecules
Read more
Targeting NF-kappaB mediated cell signaling pathway and inflammatory mediators by 1,2-diazole in A549 cells in vitro. Vinod Prabhu V et al., 2021 Mar, Biotechnol Rep (Amst)
Read more
Correlation analysis of the proportion of monocytic myeloid-derived suppressor cells in colorectal cancer patients. Shirasuna K et al., 2020, PLoS One
Read more
Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease. Yin J et al., 2016 Jul, Cancer Med
Read more